Efficacy and safety of cholestyramine therapy in peripubertal and prepubertal children with familial hypercholesterolemia
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 129 (1), 42-49
- https://doi.org/10.1016/s0022-3476(96)70188-9
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Use of cholestyramine in the treatment of children with familial combined hyperlipidemiaThe Journal of Pediatrics, 1993
- Effectiveness of low-dose colestipol therapy in patients with moderate hypercholesterolemiaThe American Journal of Cardiology, 1992
- Colestipol plus niacin therapy elevates plasma homocyst(e)ine levelsCoronary Artery Disease, 1991
- Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levelsAtherosclerosis, 1989
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisNew England Journal of Medicine, 1986
- LONG-TERM FOLLOW-UP OF CHILDREN WITH FAMILIAL HYPERCHOLESTEROLÆMIA TREATED WITH CHOLESTYRAMINEThe Lancet, 1980
- DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1977
- The effect of cholestyramine on intestinal absorption.Gut, 1975
- Use of cholestyramine in treatment of children with familial hypercholesterolaemiaArchives of Disease in Childhood, 1973